Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines
PolandStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
PolandStudy on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
PolandStudy on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis
PolandStudy on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
PolandStudy Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women
PolandStudy of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy
PolandStudy on Donanemab, Florbetapir, and Flortaucipir for Patients with Early Alzheimer's Disease
PolandStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
PolandStudy on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
